116 results on '"Höltje, Markus"'
Search Results
2. Brain-targeting autoantibodies in patients with dementia.
- Author
-
Staabs, Finja, Rasmussen, Helle Foverskov, Buthut, Maria, Höltje, Markus, Li, Lucie Y., Stöcker, Winfried, Teegen, Bianca, and Prüss, Harald
- Subjects
GLIAL fibrillary acidic protein ,DEMENTIA patients ,AUTOANTIBODIES ,ALZHEIMER'S disease ,VASCULAR dementia - Abstract
Autoantibodies against proteins in the brain are increasingly considered as a potential cause of cognitive decline, not only in subacute autoimmune encephalopathies but also in slowly progressing impairment of memory in patients with classical neurodegenerative dementias. In this retrospective cohort study of 161 well-characterized patients with different forms of dementia and 34 controls, we determined the prevalence of immunoglobulin (Ig) G and IgA autoantibodies to brain proteins using unbiased immunofluorescence staining of unfixed murine brain sections. Autoantibodies were detected in 21.1% of dementia patients and in 2.9% of gender-matched controls, with higher frequencies in vascular dementia (42%), Alzheimer's disease (30%), dementia of unknown cause (25%), and subjective cognitive impairment (16.7%). Underlying antigens involved glial fibrillary acidic protein (GFAP), glycine receptor, and Rho GTPase activating protein 26 (ARHGAP26), but also a range of yet undetermined epitopes on neurons, myelinated fiber tracts, choroid plexus, glial cells, and blood vessels. Antibody-positive patients were younger than antibody-negative patients but did not differ in the extent of cognitive impairment, epidemiological and clinical factors, or comorbidities. Further research is needed to understand the potential contribution to disease progression and symptomatology, and to determine the antigenic targets of dementia-associated autoantibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings
- Author
-
Höltje, Markus, Mertens, Robert, Schou, Morten Brix, Saether, Sverre Georg, Kochova, Elena, Jarius, Sven, Prüss, Harald, Komorowski, Lars, Probst, Christian, Paul, Friedemann, Bellmann-Strobl, Judith, Gitler, Daniel, Benfenati, Fabio, Piepgras, Johannes, Ahnert-Hilger, Gudrun, and Ruprecht, Klemens
- Published
- 2017
- Full Text
- View/download PDF
4. Correction: Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function
- Author
-
Rocchi, Anna, Sacchetti, Silvio, De Fusco, Antonio, Giovedi, Silvia, Parisi, Barbara, Cesca, Fabrizia, Höltje, Markus, Ruprecht, Klemens, Ahnert-Hilger, Gudrun, and Benfenati, Fabio
- Published
- 2020
- Full Text
- View/download PDF
5. Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function
- Author
-
Rocchi, Anna, Sacchetti, Silvio, De Fusco, Antonio, Giovedi, Silvia, Parisi, Barbara, Cesca, Fabrizia, Höltje, Markus, Ruprecht, Klemens, Ahnert-Hilger, Gudrun, and Benfenati, Fabio
- Published
- 2019
- Full Text
- View/download PDF
6. IgA autoantibodies against native myelin basic protein in a patient with MS
- Author
-
Schumacher, Heike, Wenke, Nina K., Kreye, Jakob, Höltje, Markus, Marcus, Katrin, May, Caroline, and Prüss, Harald
- Published
- 2019
- Full Text
- View/download PDF
7. C3-induced release of neurotrophic factors from Schwann cells – potential mechanism behind its regeneration promoting activity
- Author
-
Rohrbeck, Astrid, Stahl, Frank, Höltje, Markus, Hettwer, Timo, Lindner, Patrick, Hagemann, Sandra, Pich, Andreas, and Haastert-Talini, Kirsten
- Published
- 2015
- Full Text
- View/download PDF
8. Clostridial C3 proteins: Recent approaches to improve neuronal growth and regeneration
- Author
-
Höltje, Markus, Just, Ingo, and Ahnert-Hilger, Gudrun
- Published
- 2011
- Full Text
- View/download PDF
9. Brain blood vessel autoantibodies in patients with NMDA and GABAA receptor encephalitis: identification of unconventional Myosin-X as target antigen.
- Author
-
Li, Lucie Y., Kreye, Jakob, Burek, Malgorzata, Cordero-Gomez, César, Barthel, Paula C., Sánchez-Sendín, Elisa, Kornau, Hans-Christian, Schmitz, Dietmar, Scharf, Madeleine, Meybohm, Patrick, Reincke, S. Momsen, Prüss, Harald, and Höltje, Markus
- Subjects
AUTOANTIBODIES ,BLOOD-brain barrier ,METHYL aspartate receptors ,BLOOD vessels ,PURKINJE cells ,ENCEPHALITIS ,PROTEOMICS - Abstract
Introduction: The antibody repertoire from CSF-derived antibody-secreting cells and memory B-cells in patients with encephalitis contains a considerable number of antibodies that do not target the disease-defining autoantigen such as the GABA or NMDA receptors. This study focuses on the functional relevance of autoantibodies to brain blood vessels in patients with GABAA and NMDA receptor encephalitis. Methods: We tested 149 human monoclonal IgG antibodies from the cerebrospinal fluid of six patients with different forms of autoimmune encephalitis on murine brain sections for reactivity to blood vessels using immunohistochemistry. Positive candidates were tested for reactivity with purified brain blood vessels, effects on transendothelial electrical resistance (TEER), and expression of tight junction proteins as well as gene regulation using human brain microvascular endothelial hCMEC/D3 cells as in vitro blood-brain barrier model. One blood-vessel reactive antibody was infused intrathecally by pump injection in mice to study in vivo binding and effects on tight junction proteins such as Occludin. Target protein identification was addressed using transfected HEK293 cells. Results: Six antibodies reacted with brain blood vessels, three were from the same patient with GABAAR encephalitis, and the other three were from different patients with NMDAR encephalitis. One antibody from an NMDAR encephalitis patient, mAb 011-138, also reacted with cerebellar Purkinje cells. In this case, treatment of hCMEC/D3 cells resulted in decreased TEER, reduced Occludin expression, and mRNA levels. Functional relevance in vivo was confirmed as Occludin downregulation was observed in mAb 011-138-infused animals. Unconventional Myosin-X was identified as a novel autoimmune target for this antibody. Discussion: We conclude that autoantibodies to blood vessels occur in autoimmune encephalitis patients and might contribute to a disruption of the blood-brain barrier thereby suggesting a potential pathophysiological relevance of these antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Maternal synapsin autoantibodies are associated with neurodevelopmental delay.
- Author
-
Bünger, Isabel, Makridis, Konstantin L., Kreye, Jakob, Nikolaus, Marc, Sedlin, Eva, Ullrich, Tim, Hoffmann, Christian, Tromm, Johannes Vincent, Rasmussen, Helle Foverskov, Milovanovic, Dragomir, Höltje, Markus, Prüss, Harald, and Kaindl, Angela M.
- Subjects
AUTOANTIBODIES ,NEUROPLASTICITY ,NEURAL development ,DEVELOPMENTAL delay ,LEARNING disabilities - Abstract
Maternal autoantibodies can be transmitted diaplacentally, with potentially deleterious effects on neurodevelopment. Synapsin 1 (SYN1) is a neuronal protein that is important for synaptic communication and neuronal plasticity. While monoallelic loss of function (LoF) variants in the SYN1 gene result in Xlinked intellectual disability (ID), learning disabilities, epilepsy, behavioral problems, and macrocephaly, the effect of SYN1 autoantibodies on neurodevelopment remains unclear. We recruited a clinical cohort of 208 mothers and their children with neurologic abnormalities and analyzed the role of maternal SYN1 autoantibodies. We identified seropositivity in 9.6% of mothers, and seropositivity was associated with an increased risk for ID and behavioral problems. Furthermore, children more frequently had epilepsy, macrocephaly, and developmental delay, in line with the SYN1 LoF phenotype. Whether SYN1 autoantibodies have a direct pathogenic effect on neurodevelopment or serve as biomarkers requires functional experiments. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Enhancement of Phosphorylation and Transport Activity of the Neuronal Glutamate Transporter Excitatory Amino Acid Transporter 3 by C3bot and a 26mer C3bot Peptide.
- Author
-
Piepgras, Johannes, Rohrbeck, Astrid, Just, Ingo, Bittner, Stefan, Ahnert-Hilger, Gudrun, and Höltje, Markus
- Subjects
GLUTAMATE transporters ,EXCITATORY amino acids ,PEPTIDES ,BIOLOGICAL assay ,PROTEIN-tyrosine kinase inhibitors ,PROTEIN kinase C - Abstract
In primary murine hippocampal neurons we investigated the regulation of EAAT3-mediated glutamate transport by the Clostridium botulinum C3 transferase C3bot and a 26mer peptide derived from full length protein. Incubation with either enzyme-competent C3bot or enzyme-deficient C3bot
156–181 peptide resulted in the upregulation of glutamate uptake by up to 22% compared to untreated cells. A similar enhancement of glutamate transport was also achieved by the classical phorbol-ester-mediated activation of protein kinase C subtypes. Yet comparable, effects elicited by C3 preparations seemed not to rely on PKCα, γ, ε, or ζ activation. Blocking of tyrosine phosphorylation by tyrosine kinase inhibitors prevented the observed effect mediated by C3bot and C3bot 26mer. By using biochemical and molecular biological assays we could rule out that the observed C3bot and C3bot 26mer-mediated effects solely resulted from enhanced transporter expression or translocation to the neuronal surface but was rather mediated by transporter phosphorylation at tyrosine residues that was found to be significantly enhanced following incubation with either full length protein or the 26mer C3 peptide. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
12. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons
- Author
-
Höltje, Markus, Schulze, Sebastian, Strotmeier, Jasmin, Mahrhold, Stefan, Richter, Karin, Binz, Thomas, Bigalke, Hans, Ahnert-Hilger, Gudrun, and Rummel, Andreas
- Published
- 2013
- Full Text
- View/download PDF
13. N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis
- Author
-
Prüss, Harald, Finke, Carsten, Höltje, Markus, Hofmann, Joerg, Klingbeil, Christine, Probst, Christian, Borowski, Kathrin, Ahnert-Hilger, Gudrun, Harms, Lutz, Schwab, Jan M., Ploner, Christoph J., Komorowski, Lars, Stoecker, Winfried, Dalmau, Josep, and Wandinger, Klaus-Peter
- Published
- 2012
- Full Text
- View/download PDF
14. Minimal essential length of Clostridium botulinum C3 peptides to enhance neuronal regenerative growth and connectivity in a non-enzymatic mode
- Author
-
Loske, Peter, Boato, Francesco, Hendrix, Sven, Piepgras, Johannes, Just, Ingo, Ahnert-Hilger, Gudrun, and Höltje, Markus
- Published
- 2012
- Full Text
- View/download PDF
15. Expression of the voltage- and Ca2+-dependent BK potassium channel subunits BKβ1 and BKβ4 in rodent astrocytes
- Author
-
Seidel, Katharina N., Derst, Christian, Salzmann, Mikhail, HöLtje, Markus, Priller, Josef, Markgraf, René, Heinemann, Stefan H., Heilmann, Heike, Skatchkov, Serguei N., Eaton, Misty J., Veh, RüDiger W., and Prüss, Harald
- Published
- 2011
- Full Text
- View/download PDF
16. Role of Rho GTPase in astrocyte morphology and migratory response during in vitro wound healing
- Author
-
Höltje, Markus, Hoffmann, Anja, Hofmann, Fred, Mucke, Christian, Groe, Gisela, Van Rooijen, Nico, Kettenmann, Helmut, Just, Ingo, and Ahnert-Hilger, Gudrun
- Published
- 2005
17. Functional G-protein heterotrimers are associated with vesicles of putative glutamatergic terminals: implications for regulation of transmitter uptake
- Author
-
Pahner, Ingrid, Höltje, Markus, Winter, Sandra, Takamori, Shigeo, Bellocchio, Elizabeth E, Spicher, Karsten, Laake, Petter, Nümberg, Bernd, Ottersen, Ole Petter, and Ahnert-Hilger, Gudrun
- Published
- 2003
- Full Text
- View/download PDF
18. The Higher Sensitivity of GABAergic Compared to Glutamatergic Neurons to Growth-Promoting C3bot Treatment Is Mediated by Vimentin.
- Author
-
Adolf, Andrej, Turko, Paul, Rohrbeck, Astrid, Just, Ingo, Vida, Imre, Ahnert-Hilger, Gudrun, and Höltje, Markus
- Subjects
GABAERGIC neurons ,VIMENTIN ,NEURONS ,CLOSTRIDIUM botulinum ,BRANCHING processes ,DENDRITES - Abstract
The current study investigates the neurotrophic effects of Clostridium botulinum C3 transferase (C3bot) on highly purified, glia-free, GABAergic, and glutamatergic neurons. Incubation with nanomolar concentrations of C3bot promotes dendrite formation as well as dendritic and axonal outgrowth in rat GABAergic neurons. A comparison of C3bot effects on sorted mouse GABAergic and glutamatergic neurons obtained from newly established NexCre ; Ai9xVGAT Venus mice revealed a higher sensitivity of GABAergic cells to axonotrophic and dendritic effects of C3bot in terms of process length and branch formation. Protein biochemical analysis of known C3bot binding partners revealed comparable amounts of β1 integrin in both cell types but a higher expression of vimentin in GABAergic neurons. Accordingly, binding of C3bot to GABAergic neurons was stronger than binding to glutamatergic neurons. A combinatory treatment of glutamatergic neurons with C3bot and vimentin raised the amount of bound C3bot to levels comparable to the ones in GABAergic neurons, thereby confirming the specificity of effects. Overall, different surface vimentin levels between GABAergic and glutamatergic neurons exist that mediate neurotrophic C3bot effects. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Subtle Phenotype Differences in Psychiatric Patients With and Without Serum Immunoglobulin G Antibodies to Synapsin.
- Author
-
Sæther, Sverre Georg, Vaaler, Arne, Evjenth, Anita, Aune, Therese, Höltje, Markus, Ruprecht, Klemens, and Schou, Morten
- Subjects
IMMUNOGLOBULIN G ,PSYCHOTHERAPY patients ,ANTI-NMDA receptor encephalitis ,MENTAL health services ,IMMUNOGLOBULINS ,CEREBROSPINAL fluid ,HYPERCOAGULATION disorders ,DELUSIONS - Abstract
The discovery that antibodies targeting neuronal antigens can induce severe psychiatric symptoms has been a significant progress in the understanding of psychiatric disorders. Antibodies targeting synapsin I in serum and cerebrospinal fluid (CSF) were first reported in 2015 in a patient with limbic encephalitis. Because of its regulatory function for neurotransmitter release, synapsin I has been suggested to play a role in psychiatric disorders. It is, however, unknown whether or not synapsin antibodies are of clinical significance in patients with psychiatric disorders. In the present study, we aimed to investigate if synapsin I immunoglobulin (Ig)G serum antibody positive patients admitted to acute psychiatric care have a different psychiatric phenotype than synapsin IgG antibody negative patients. A total of 13 anti-synapsin positive patients were matched for age, sex, and psychiatric diagnosis with 39 anti-synapsin negative patients from the same cohort. The groups were compared regarding 11 clinical features frequently seen in anti-neuronal antibody associated disorders. Anti-synapsin positive patients had higher agitation scores as measured with the Positive and Negative Syndrome Scale Excited Component [median (interquartile range) 11 (8) versus 7 (7), p = 0.04] compared to controls. However, the absolute scores were low in both groups, and the difference may not be clinically significant. Other clinical features assessed (e.g. hallucinations, delusions) did not differ between groups. We conclude that synapsin serum IgG antibodies lack syndrome specificity in patients admitted to acute psychiatric inpatient care. However, further studies addressing functional effects of synapsin antibodies are needed to conclude whether or not they have a pathophysiological relevance. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. Release of astroglial vimentin by extracellular vesicles: Modulation of binding and internalization of C3 transferase in astrocytes and neurons.
- Author
-
Adolf, Andrej, Rohrbeck, Astrid, Münster‐Wandowski, Agnieszka, Johansson, Malin, Kuhn, Hans‐Georg, Kopp, Marcel Alexander, Brommer, Benedikt, Schwab, Jan Markus, Just, Ingo, Ahnert‐Hilger, Gudrun, and Höltje, Markus
- Published
- 2019
- Full Text
- View/download PDF
21. Epitope specificity of anti-synapsin autoantibodies: Differential targeting of synapsin I domains.
- Author
-
Mertens, Robert, Melchert, Sarah, Gitler, Daniel, Schou, Morten Brix, Saether, Sverre Georg, Vaaler, Arne, Piepgras, Johannes, Kochova, Elena, Benfenati, Fabio, Ahnert-Hilger, Gudrun, Ruprecht, Klemens, and Höltje, Markus
- Subjects
PRESYNAPTIC receptors ,NEUROTRANSMITTER receptors ,SYNAPSINS ,IMMUNOGLOBULIN G ,NEUROLOGICAL disorders - Abstract
Objective: To identify the specific domains of the presynaptic protein synapsin targeted by recently described autoantibodies to synapsin. Methods: Sera of 20 and CSF of two patients with different psychiatric and neurological disorders previously tested positive for immunoglobulin (Ig)G antibodies to full-length synapsin were screened for IgG against synapsin I domains using HEK293 cells transfected with constructs encoding different domains of rat synapsin Ia. Additionally, IgG subclasses were determined using full-length synapsin Ia. Serum and CSF from one patient were also screened for IgA autoantibodies to synapsin I domains. Sera from nine and CSF from two healthy subjects were analyzed as controls. Results: IgG in serum from 12 of 20 IgG synapsin full-length positive patients, but from none of the healthy controls, bound to synapsin domains. Of these 12 sera, six bound to the A domain, five to the D domain, and one to the B- (and possibly A-), D-, and E-domains of synapsin I. IgG antibodies to the D-domain were also detected in one of the CSF samples. Determination of IgG subclasses detected IgG
1 in two sera and one CSF, IgG2 in none of the samples, IgG3 in two sera, and IgG4 in eight sera. One patient known to be positive for IgA antibodies to full-length synapsin had IgA antibodies to the D-domain in serum and CSF. Conclusions: Anti-synapsin autoantibodies preferentially bind to either the A- or the D-domain of synapsin I. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
22. The intermediate filament protein vimentin is essential for axonotrophic effects of Clostridium botulinum C3 exoenzyme.
- Author
-
Adolf, Andrej, Leondaritis, George, Rohrbeck, Astrid, Eickholt, Britta Johanna, Just, Ingo, Ahnert‐Hilger, Gudrun, and Höltje, Markus
- Subjects
CLOSTRIDIUM botulinum ,VIMENTIN ,NEURAL physiology ,EXTRACELLULAR enzymes ,AXONS ,ADP-ribosylation ,NEUROGLIA - Abstract
The type III intermediate filament protein vimentin was recently identified to mediate binding and uptake of Clostridium botulinum C3 exoenzyme (C3bot) in two cell lines. Here, we used primary neuronal cultures from vimentin knockout (Vim
−/− ) mice to study the impact of vimentin on axonal growth and internalization of C3bot. In contrast to wild type, vimentin knockout neurons were insensitive to C3bot. Application of extracellular vimentin to Vim−/− neurons completely restored the growth-promoting effects of C3bot. In line with this uptake of C3bot into Vim−/− neurons was strongly decreased resulting in reduced ADP-ribosylation of RhoA and B as detected by an antibody recognizing selectively ADP-ribosylated RhoA/B. Again, uptake of C3bot into Vim−/− neurons was rescued by addition of extracellular vimentin. In addition, in purified embryonic stem cell-derived motor neurons that are devoid of glial cells C3bot elicited axonotrophic effects confining neuronal vimentin as a binding partner. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
23. Studying Axonal Outgrowth and Regeneration of the Corticospinal Tract in Organotypic Slice Cultures.
- Author
-
Pohland, Martin, Glumm, Robert, Stoenica, Luminita, Höltje, Markus, Kiwit, Jürgen, Ahnert-Hilger, Gudrun, Strauss, Ulf, Bräuer, Anja U., Paul, Friedemann, and Glumm, Jana
- Published
- 2015
- Full Text
- View/download PDF
24. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.
- Author
-
Piepgras, Johannes, Höltje, Markus, Michel, Klaus, Li, Qin, Otto, Carolin, Drenckhahn, Christoph, Probst, Christian, Schemann, Michael, Jarius, Sven, Stöcker, Winfried, Balint, Bettina, Meinck, Hans-Michael, Buchert, Ralph, Dalmau, Josep, Ahnert-Hilger, Gudrun, and Ruprecht, Klemens
- Published
- 2015
- Full Text
- View/download PDF
25. Anti-DPPX encephalitis.
- Author
-
Piepgras, Johannes, Höltje, Markus, Michel, Klaus, Qin Li, Otto, Carolin, Drenckhahn, Christoph, Probst, Christian, Schemann, Michael, Jarius, Sven, Stöcker, Winfried, Balint, Bettina, Meinck, Hans-Michael, Buchert, Ralph, Dalmau, Josep, Ahnert-Hilger, Gudrun, and Ruprecht, Klemens
- Published
- 2015
- Full Text
- View/download PDF
26. Synaptic Vesicle Proteins: Targets and Routes for Botulinum Neurotoxins.
- Author
-
Ahnert-Hilger, Gudrun, Münster-Wandowski, Agnieszka, and Höltje, Markus
- Published
- 2013
- Full Text
- View/download PDF
27. High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.
- Author
-
Doss, Sarah, Wandinger, Klaus‐Peter, Hyman, Bradley T., Panzer, Jessica A., Synofzik, Matthis, Dickerson, Bradford, Mollenhauer, Brit, Scherzer, Clemens R., Ivinson, Adrian J., Finke, Carsten, Schöls, Ludger, Müller vom Hagen, Jennifer, Trenkwalder, Claudia, Jahn, Holger, Höltje, Markus, Biswal, Bharat B., Harms, Lutz, Ruprecht, Klemens, Buchert, Ralph, and Höglinger, Günther U.
- Subjects
ASPARTATE receptors ,DEMENTIA patients ,NEURODEGENERATION ,IMMUNOGLOBULINS ,IMMUNOTHERAPY - Abstract
Objective To retrospectively determine the frequency of N-Methyl-D-Aspartate ( NMDA) receptor ( NMDAR) autoantibodies in patients with different forms of dementia. Methods Clinical characterization of 660 patients with dementia, neurodegenerative disease without dementia, other neurological disorders and age-matched healthy controls combined with retrospective analysis of serum or cerebrospinal fluid ( CSF) for the presence of NMDAR antibodies. Antibody binding to receptor mutants and the effect of immunotherapy were determined in a subgroup of patients. Results Serum NMDAR antibodies of IgM, IgA, or IgG subtypes were detected in 16.1% of 286 dementia patients (9.5% IgM, 4.9% IgA, and 1.7% IgG) and in 2.8% of 217 cognitively healthy controls (1.9% IgM and 0.9% IgA). Antibodies were rarely found in CSF. The highest prevalence of serum antibodies was detected in patients with 'unclassified dementia' followed by progressive supranuclear palsy, corticobasal syndrome, Parkinson's disease-related dementia, and primary progressive aphasia. Among the unclassified dementia group, 60% of 20 patients had NMDAR antibodies, accompanied by higher frequency of CSF abnormalities, and subacute or fluctuating disease progression. Immunotherapy in selected prospective cases resulted in clinical stabilization, loss of antibodies, and improvement of functional imaging parameters. Epitope mapping showed varied determinants in patients with NMDAR IgA-associated cognitive decline. Interpretation Serum IgA/IgM NMDAR antibodies occur in a significant number of patients with dementia. Whether these antibodies result from or contribute to the neurodegenerative disorder remains unknown, but our findings reveal a subgroup of patients with high antibody levels who can potentially benefit from immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
28. Vimentin Mediates Uptake of C3 Exoenzyme.
- Author
-
Rohrbeck, Astrid, Schröder, Anke, Hagemann, Sandra, Pich, Andreas, Höltje, Markus, Ahnert-Hilger, Gudrun, and Just, Ingo
- Subjects
VIMENTIN ,EXTRACELLULAR enzymes ,CLOSTRIDIUM botulinum ,BIOCHEMICAL substrates ,ADP-ribosylation ,CYTOLOGY ,EUKARYOTIC cells - Abstract
Clostridium botulinum C3 exoenzyme (C3) selectively inactivates RhoA/B/C GTPases by ADP-ribosylation. Based on this substrate specificity C3 is a well-established tool in cell biology. C3 is taken up by eukaryotic cells although lacking an uptake and translocation domain. Based on different approaches vimentin was identified as membranous C3-interaction partner by mass spectrometry. Vimentin in fact was partly localized at the outer surface of hippocampal HT22 cells and J744A.1 macrophages. Domain analysis identified the rod domain as binding partner of C3. Vimentin was also involved in uptake of C3 as shown by knock down of vimentin in HT22 and J774A.1 cells. The involvement of vimentin in uptake of C3 was further supported by the findings that the vimentin disruptor acrylamide blocked uptake of C3. Vimentin is not only a major organizing element of the intermediate filament network but is also involved in both binding and uptake of C3 exoenzyme. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
29. Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons
- Author
-
Scheuch, Kathrin, Höltje, Markus, Budde, Holger, Lautenschlager, Marion, Heinz, Andreas, Ahnert-Hilger, Gudrun, and Priller, Josef
- Subjects
- *
LITHIUM , *TRYPTOPHAN , *SEROTONIN , *NEURONS , *BIPOLAR disorder , *POLYMERASE chain reaction , *GENE expression - Abstract
Abstract: Lithium salts are mood-stabilizing agents with acute antimanic properties and proven efficacy in the long-term prevention of manic and depressive episodes. Furthermore, lithium augmentation is a well-established strategy to treat depressed patients, which do not respond to antidepressants alone. There is evidence to suggest that these effects of lithium are due to a synergism with central serotonin (5-HT) neurotransmission. In this study, we investigated the effects of lithium chloride (LiCl, 1 mM) on 5-HT uptake and release in primary serotonergic neurons from rat raphe nuclei. Short-term (8 h) and long-term (14 days) treatment with LiCl resulted in a 20% and 23% increase in 5-HT release, but neither influenced 5-HT uptake across the plasma membrane nor vesicular 5-HT uptake. In lithium-treated raphe neurons, the inhibition of 5-HT uptake by fluoxetine was unchanged. Using real-time reverse transcriptase polymerase chain reaction and Western blotting, we examined the effect of lithium on tryptophan hydroxylase 2 (TPH2) expression, the rate-limiting enzyme in brain 5-HT biosynthesis. Short-term lithium treatment resulted in a 45% decrease in tph2 mRNA expression and a 31% reduction of TPH2 protein levels, which was completely compensated after long-term treatment. Our results suggest that lithium can modify tph2 gene expression and 5-HT release in raphe neurons, providing new insight into the serotonergic mechanisms of action of lithium. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
30. A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation.
- Author
-
Höltje, Markus, Djalali, Susann, Hofmann, Fred, Münster-Wandowski, Agnieszka, Hendrix, Sven, Boato, Francesco, Dreger, Stefanie C., Große, Gisela, Henneberger, Christian, Grantyn, Rosemarie, Just, Ingo, and Ahnert-Hilger, Gudrun
- Subjects
- *
AMINO acids , *CLOSTRIDIUM botulinum , *PROTEINS , *NEURON development , *RHO GTPases - Abstract
Small GTPases of the Rho family play versatile roles in the formation and development of axons and dendrites, effects often studied by the Rho-inactivating C3 transferase (C3bot) from Clostridium botulinum. Recently, we reported that transferase-deficient C3bot also exerted axonotrophic activity. Using overlapping peptides from the C3bot sequence, we identified a small peptide of 29 amino acids (covering residues 154-182) from the C-terminal region of C3bot that promotes both axonal and dendritic growth, as well as branching of hippocampal neurons, at submicromolar concentrations. Several C3bot constructs, including the short peptide, enhanced the number of axonal segments from mid- to higher-order segments. C3bot154-182 also increased the number of synaptophysin-expressing terminals, up-regulated various synaptic proteins, and functionally increased the glutamate uptake. Staining against the vesicular glutamate and GABA transporters further revealed that the effect was attributable to a higher number of glutamatergic and GABAergic inputs on proximal dendrites of enhanced green fluorescent protein (EGFP)-transfected neurons. Using organotypical slice cultures, we also detected trophic effects of C3bot154-182 on length and density of outgrowing fibers from the entorhinal cortex that were comparable to the effects elicited by full-length C3bot. In addition, an enhanced reinnervation was observed in a hippocampal-entorhinal lesion model. In summary, the neurotrophic effect of C3bot is executed by a C-terminal peptide fragment covering aa 154-182 of C3; it triggers dendritic and axonal growth and branching as well as increased synaptic connectivity. In contrast to full-length C3, this C3 peptide selectively acts on neurons but not on glial cells. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
31. Inhibition of Rho-dependent pathways by Clostridium botulinum C3 protein induces a proinflammatory profile in microglia.
- Author
-
Hoffmann, Anja, Hofmann, Fred, Just, Ingo, Lehnardt, Seija, Hanisch, Uwe-Karsten, Brück, Wolfgang, Kettenmann, Helmut, Ahnert-Hilger, Gudrun, and Höltje, Markus
- Published
- 2008
- Full Text
- View/download PDF
32. Glutamate Uptake and Release by Astrocytes Are Enhanced by Clostridium botulinum C3 Protein.
- Author
-
Höltje, Markus, Hofmann, Fred, Lux, Romy, Veh, Rudiger W., Just, Ingo, and Ahnert-Hilger, Gudrun
- Subjects
- *
CLOSTRIDIUM , *CELLS , *BOTULINUM toxin , *NEURAL stem cells , *EXCRETION - Abstract
Inhibition of Rho activity by Clostridium botulinum C3 transferase (C3bot) versatily changes functional properties of neural cells. Using cultivated mouse astrocytes, we show here that C3bot increases both uptake and secretion of glutamate. The enhanced glutamate uptake is initiated by an NFκB-dependent up-regulation of the glial glutamate transporter 1 that is efficaciously sorted to the plasma membrane. The increase in cytosolic glutamate concentration promotes vesicular glutamate storage in astrocytes treated with C3bot. Parallel to the increased storage, C3-induced impairment of Rho-dependent pathways strongly enhances Ca2+-dependent secretion of glutamate. This is accompanied by higher levels of the SNARE protein synaptobrevin. Synaptobrevin inactivation by botulinum neurotoxin D almost completely inhibits Ca2+-dependent glutamate secretion triggered by C3bot, indicating that the enhanced release of glutamate mainly originates from exocytosis. In addition, C3bot increases the exocytosis/endocytosis turnover, as analyzed by the stimulated accumulation of the fluorescent dye AM1-43. The release of glutamine, the main metabolite of glutamate, is only moderately affected by C3bot. In conclusion, inhibition of Rho-dependent pathways shifts astrocytes to a secretory active stage in which they may modulate neuronal excitability. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
33. Gαo2 Regulates Vesicular Glutamate Transporter Activity by Changing Its Chloride Dependence.
- Author
-
Winter, Sandra, Brunk, Irene, Walther, Diego J., Höltje, Markus, Meisheng Jiang, Peter, Jens-Uwe, Takamori, Shigeo, Jahn, Reinhard, Birnbaumer, Lutz, and Ahnert-Hilger, Gudrun
- Subjects
NEUROTRANSMITTERS ,CHLORIDE cells ,PRESYNAPTIC receptors ,MATERIAL plasticity ,MONOCLONAL antibodies - Abstract
Classical neurotransmitters, including monoamines, acetylcholine, glutamate, GABA, and glycine, are loaded into synaptic vesicles by means of specific transporters. Vesicular monoamine transporters are under negative regulation by α subunits of trimeric G-proteins, including Gα
o2 and Gαq . Furthermore, glutamate uptake, mediated by vesicular glutamate transporters (VGLUTs), is decreased by the nonhydrolysable GTP-analog guanylylimidodiphosphate. Using mutant mice lacking various Ga subunits, including Gαo1 Gαo2 , Gαq , and Gα11 , and a Gαo2 -Specific monoclonal antibody, we now show that VGLUTs are exclusively regulated by Gαo2 . G-protein activation does not affect the electrochemical proton gradient serving as driving force for neurotransmitter uptake; rather, Gαo2 exerts its action by specifically affecting the chloride dependence of VGLUTs. All VGLUTs show maximal activity at ∼5 mM chloride. Activated Gαo2 shifts this maximum to lower chloride concentrations. In contrast, glutamate uptake by vesicles isolated from Gαo2 -/- mice have completely lost chloride activation. Thus, Gαo2 acts on a putative regulatory chloride binding domain that appears to modulate transport activity of vesicular glutamate transporters. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
34. Rapid mechano-sensory pathways code leg impact and elicit very rapid reflexes in insects.
- Author
-
Höltje, Markus and Hustert, Reinhold
- Subjects
- *
MECHANORECEPTORS , *MOTOR neurons , *CENTRAL nervous system - Abstract
The temporal sequence of mechanoreceptor input arriving at the motoneuron level in the central nervous system (CNS) after distal mechanical contact was studied for the locust middle leg. Different types of afferent information from potential contact areas after selective stimulation showed propagation times of no less than 8 ms from mechanosensory hairs, campaniform sensilla (CS) and spurs of the distal leg segments. Impact of the same mechanical stimuli, even if very delicate, elicits strain that is transferred in less than 1 ms via the cuticle and stimulates proximal CS on the trochanter and femur. These propagate the afferents that code distal leg contact in about 1 ms to the CNS, where they connect monoand polysynaptically to motoneurons of the depressor trochanteris system. The elicited excitatory postsynaptic potentials (EPSPs) contribute to rapid efferent commands, since single EPSPs already rise near firing threshold of the motoneurons. The short delays in this mechano-neuronal muscular pathway from the tip of a leg to the neuromuscular synapses (5-7 ms) can very rapidly raise muscle tension in the trochanteral depressors at new leg contacts during locust landing and locomotion. At substrate contact, proximal leg CS contribute to very rapid motor responses supporting the body. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
35. The Vesicular Monoamine Content Regulates VMAT2 Activity through Gα[sub q] in Mouse Platelets.
- Author
-
Höltje, Markus, Winter, Sandra, Walther, Diego, Pahner, Ingrid, Hörtnagl, Heide, Ottersen, Ole Petter, Bader, Michael, and Ahnert-Hilger, Gudrun
- Subjects
- *
GUANOSINE triphosphate , *SEROTONINERGIC mechanisms , *ADRENERGIC mechanisms - Abstract
Shows the ability of vesicular monoamine content to regulate vesicular monoamine transmitter transporters (VMAT2) activity through Galpha[sub q] in mouse platelets. Down-regulation of the VMAT2 activity by the G protein activator guanosine triphosphate; Indirect involvement of serotonorgic, adrenergic and thromboxane A[sub 2] receptors in the down-regulation of VMAT2 activity.
- Published
- 2003
- Full Text
- View/download PDF
36. C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts.
- Author
-
Boato, Francesco, Hendrix, Sven, Huelsenbeck, Stefanie C., Hofmann, Fred, Große, Gisela, Djalali, Susann, Klimaschewski, Lars, Auer, Maria, Just, Ingo, Ahnert-Hilger, Gudrun, and Höltje, Markus
- Subjects
PEPTIDES ,SPINAL cord diseases ,REGENERATION (Biology) ,PYRAMIDAL tract ,LABORATORY animals ,SEROTONINERGIC mechanisms - Abstract
Functional recovery and regeneration of corticospinal tract (CST) fibers following spinal cord injury by compression or dorsal hemisection in mice was monitored after application of the enzyme-deficient Clostridium botulinum C3-protein-derived 29-amino-acid fragment C3bot
154-182 . This peptide significantly improved locomotor restoration in both injury models as assessed by the open-field Basso Mouse Scale for locomotion test and Rotarod treadmill experiments. These data were supported by tracing studies showing an enhanced regenerative growth of CST fibers in treated animals as visualized by anterograde tracing. Additionally, C3bot154-182 stimulated regenerative growth of raphespinal fibers and improved serotonergic input to lumbar α-motoneurons. These in vivo data were confirmed by in vitro data, showing an enhanced axon outgrowth of α-motoneurons and hippocampal neurons cultivated on normal or growth-inhibitory substrates after application of C3bot154-182 . The observed effects were probably caused by a non-enzymatic downregulation of active RhoA by the C3 peptide as indicated by pull-down experiments. By contrast, C3bot154-182 did not induce neurite outgrowth in primary cultures of dorsal root ganglion cells. In conclusion, C3bot154-182 represents a novel, promising tool to foster axonal protection and/or repair, as well as functional recovery after traumatic CNS injury. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
37. Erratum to “Functional G-protein heterotrimers are associated with vesicles of putative glutamatergic terminals: implications for regulation of transmitter uptake”: [Mol. Cell. Neurosci. 23 (2003) 398-413]☆
- Author
-
Pahner, Ingrid, Höltje, Markus, Winter, Sandra, Takamori, Shigeo, Bellocchio, Elizabeth E., Spicher, Karsten, Laake, Petter, Nürnberg, Bernd, Ottersen, Ole Petter, and Ahnert-Hilger, Gudrun
- Published
- 2003
- Full Text
- View/download PDF
38. Time of Day-dependent Sorting of the Vesicular Glutamate Transporter to the Plasma Membrane.
- Author
-
Darna, Mahesh, Schmutz, Isabelle, Richter, Karin, Yelamanchili, Sowmya V., Pendyala, Gurudutt, Höltje, Markus, Albrecht, Urs, and Ahnert-Hilger, Gudrun
- Subjects
- *
GLUTAMIC acid , *GLUTAMATE decarboxylase , *NEURAL transmission , *CELL membranes , *GABA - Abstract
Neurotransmitters are concentrated into synaptic vesicles by VGLUT (vesicular glutamate transporter) or VGAT (vesicular GABA transporter). The number of VGLUTs per vesicle determines the amount of stored neurotransmitter, thereby influencing postsynaptic response. Recently, we described a strong diurnal cycling of the amount of VGLUT1 on synaptic vesicles prepared from whole mouse brain at different times of the day (Yelamanchili, S. V., Pendyala, G., Brunk, I., Darna, M., Albrecht, U., and Ahnert-Hilger, G. (2006)1. Biol. Chem. 281, 15671- 15679). To analyze whether and how much VGLUT resides in cellular versus vesicular membranes, we developed a Pronase assay. We found that VGLUT and synaptotagmin are highly accessible to proteolytic cleavage in rat and mouse synaptosomal preparations, indicating considerable amounts of these vesicular proteins at the plasma membrane, whereas only minor amounts of synaptophysin and Rab3 are digested. Sucrose stimulation increases digestion of VGLUT, synaptotagmin, and synaptophysin due to membrane fusion that exposes the lumen- facing peptides to the extracellular space. Digestion of mouse synaptosomes prepared at different times of the day revealed a diurnal cycling of VGLUT to the plasma membrane. More VGLUT is digested at noon (Zeitgeber time 6) compared with the start of the light period (Zeitgeber time 0), whereas digestion of synaptophysin and synaptotagmin is independent of diurnal cycling. In contrast to VGLUT, the amount of VGAT appears not to vary diurnally but is decreased in membrane preparations from animals kept under constant darkness. We conclude that VGLUTs are sorted diurnally to the plasma membrane to modulate glutamate transmission during a day/night cycle, whereas VGAT expression is not oscillating but is increased in the presence of a light/dark cycle. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
39. The First Luminal Domain of Vesicular Monoamine Transporters Mediates G-protein-dependent Regulation of Transmitter Uptake*.
- Author
-
Irene Brunk, Christian Biex, Rachakonda, Sivaramakrishna, Höltje, Markus, Winter, Sandra, Pahner, Ingrid, Waither, Diego J., and Ahnert-Hiiger, Gudrun
- Subjects
- *
G proteins , *PHYSIOLOGICAL control systems , *CELLS , *OVARIES , *HAMSTERS - Abstract
The activity of vesicular monoamine transporters (VMATs) is down-regulated by the G-protein α-subunits of Go2 and Gq, but the signaling pathways are not known. We show here that no such regulation is observed when VMAT1 or VMAT2 are expressed in Chinese hamster ovary (CHO) cells. However, when the intracellular compartments of VMAT-expressing CHO cells are preloaded with different monoamines, transport becomes susceptible to G-protein-dependent regulation, with differences between the two transporter isoforms. Epinephrine induces G-protein-mediated inhibition of transmitter uptake in CHOVMAT1 cells but prevents inhibition induced by dopamine in CHOVMAT2 cells. Epinephrine also antagonizes G-protein-mediated inhibition of monoamine uptake by VMAT2 expressing platelets or synaptic vesicles. In CHOVMAT2 cells G-protein-mediated inhibition of monoamine uptake can be induced by 5-hydroxytryptamine (serotonin) 1B receptor agonists, whereas a! receptor agonists modulate uptake into CHOVMAT1 cells. Accordingly, 5-hydroxytryptamine 1B receptor antagonists prevent G-protein-mediated inhibition of uptake in partially filled platelets and synaptic vesicles expressing VMAT2. CHO cells expressing VMAT mutants with a shortened first vesicular loop transport monoamines. However, no or a reduced G-protein regulation of uptake can be initiated. In conclusion, vesicular content is involved in the activation of vesicle associated G-proteins via a structure sensing the luminal monoamine content. The first luminal loop of VMATs may represent a G-protein-coupled receptor that adapts vesicular filling. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
40. Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain
- Author
-
Große, Gisela, Djalali, Susann, Deng, Dong Rui, Höltje, Markus, Hinz, Britta, Schwartzkopff, Katharina, Cygon, Marcel, Rothe, Thomas, Stroh, Thomas, Hellweg, Rainer, Ahnert-Hilger, Gudrun, and Hörtnagl, Heide
- Subjects
- *
NEUROPEPTIDES , *GASTROINTESTINAL hormones , *SOMATOSTATIN , *NERVE tissue proteins , *NEUROTRANSMITTERS - Abstract
Abstract: The effects of brain-derived neurotrophic factor (BDNF) on the development of presynaptic terminals and of neuronal subtypes in various brain areas were studied in BDNF-knockout (BDNF−/−) mice at postnatal days 15–17. Western analysis revealed no changes in the overall amount of a variety of synaptic proteins in BDNF−/− mice as compared to wild type mice. In addition, the complex between the vesicular proteins, synaptophysin and synaptobrevin, as well as their respective homodimers were unaltered. Moreover, no changes in the density of neurons were found in, e.g., the CA3 region of the hippocampus and the nucleus nervi facialis of BDNF−/− mice. However, cholinergic cells were reduced by 20% in the medial septum of BDNF−/− mice associated with a decrease in the activity of choline acetyltransferase and protein levels of nerve growth factor in the hippocampus by 16% and 44%, respectively. In the striatum, however, the total number of cholinergic cells were comparable in both groups, although the activity of choline acetyltransferase was decreased by 46%. In GABAergic interneurons, the expression of neuropeptides in various brain areas was differentially affected by BDNF deletion as revealed by immunohistochemistry. In the hippocampus and cortex of BDNF−/− mice, the density of neuropeptide Y-, somatostatin-, and parvalbumin-immunoreactive cells was drastically reduced, whereas the density of calretinin-positive cells was increased. The extent of these changes in neuropeptide-containing cells varied among hippocampal subregions. In the striatum, only the density of parvalbumin-immunoreactive cells was decreased by approximately 45%. In conclusion, BDNF deficiency is accompanied by a differential dysregulation in the expression of neuropeptides and calcium-binding proteins in otherwise intact GABAergic and glutamatergic neurons in a region-specific manner. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
41. Serotonylation of Small GTPases Is a Signal Transduction Pathway that Triggers Platelet α-Granule Release
- Author
-
Walther, Diego J., Peter, Jens-Uwe, Winter, Sandra, Höltje, Markus, Paulmann, Nils, Grohmann, Maik, Vowinckel, Jakob, Alamo-Bethencourt, Victor, Wilhelm, Claudia S., Ahnert-Hilger, Gudrun, and Bader, Michael
- Subjects
- *
SEROTONIN , *CENTRAL nervous system , *VASOCONSTRICTORS , *BLOOD platelets - Abstract
Serotonin is a neurotransmitter in the central nervous system. In the periphery, serotonin functions as a ubiquitous hormone involved in vasoconstriction and platelet function. Serotonin is synthesized independently in peripheral tissues and neurons by two different rate-limiting tryptophan hydroxylase (TPH) isoenzymes. Here, we show that mice selectively deficient in peripheral TPH and serotonin exhibit impaired hemostasis, resulting in a reduced risk of thrombosis and thromboembolism, although the ultrastructure of the platelets is not affected. While the aggregation of serotonin-deficient platelets in vitro is apparently normal, their adhesion in vivo is reduced due to a blunted secretion of adhesive α-granular proteins. In elucidating the mechanism further, we demonstrate that serotonin is transamidated to small GTPases by transglutaminases during activation and aggregation of platelets, rendering these GTPases constitutively active. Our data provides evidence for a receptor-independent signaling mechanism, termed herein as “serotonylation,” which leads to α-granule exocytosis from platelets. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
42. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
- Author
-
Kreye, Jakob, Reincke, S. Momsen, Kornau, Hans-Christian, Sánchez-Sendin, Elisa, Corman, Victor Max, Liu, Hejun, Yuan, Meng, Wu, Nicholas C., Zhu, Xueyong, Lee, Chang-Chun D., Trimpert, Jakob, Höltje, Markus, Dietert, Kristina, Stöffler, Laura, von Wardenburg, Niels, van Hoof, Scott, Homeyer, Marie A., Hoffmann, Julius, Abdelgawad, Azza, and Gruber, Achim D.
- Subjects
- *
COVID-19 , *SARS-CoV-2 , *MONOCLONAL antibodies , *VIRAL antibodies , *HAMSTERS , *IMMUNOGLOBULINS , *PATHOLOGY - Abstract
The emergence of SARS-CoV-2 led to pandemic spread of coronavirus disease 2019 (COVID-19), manifesting with respiratory symptoms and multi-organ dysfunction. Detailed characterization of virus-neutralizing antibodies and target epitopes is needed to understand COVID-19 pathophysiology and guide immunization strategies. Among 598 human monoclonal antibodies (mAbs) from 10 COVID-19 patients, we identified 40 strongly neutralizing mAbs. The most potent mAb, CV07-209, neutralized authentic SARS-CoV-2 with an IC 50 value of 3.1 ng/mL. Crystal structures of two mAbs in complex with the SARS-CoV-2 receptor-binding domain at 2.55 and 2.70 Å revealed a direct block of ACE2 attachment. Interestingly, some of the near-germline SARS-CoV-2-neutralizing mAbs reacted with mammalian self-antigens. Prophylactic and therapeutic application of CV07-209 protected hamsters from SARS-CoV-2 infection, weight loss, and lung pathology. Our results show that non-self-reactive virus-neutralizing mAbs elicited during SARS-CoV-2 infection are a promising therapeutic strategy. • Characterization of potent human monoclonal SARS-CoV-2-neutralizing antibodies • Some SARS-CoV-2 antibodies reacted with mammalian self-antigens in different organs • Crystal structures of two antibodies in complex with SARS-CoV-2 RBD at 2.55/2.70 Å • Post-exposure antibody treatment protected from lung damage in infected hamsters Kreye et al. report isolation and characterization of monoclonal antibodies from COVID-19 patients, some of which were found to display autoreactivity with mammalian self-antigens in different organs. Crystal structures of two antibodies in complex with the SARS-CoV-2 spike RBD reveal antibody engagement with the ACE2 binding site from different approach angles. One antibody was evaluated further for in vivo efficacy and found to be both protective and efficacious post-challenge in a hamster infection model. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
43. Immunoreactivity to astrocytes in different forms of dementia: High prevalence of autoantibodies to GFAP.
- Author
-
Barthel PC, Staabs F, Li LY, Buthut M, Otto C, Ruprecht K, Prüss H, and Höltje M
- Abstract
Objective: To study the prevalence of autoantibodies to glial and neuronal antigens with a focus on glial acidic fibrillary protein (GFAP) in patients with dementia., Methods: Sera of 127 patients with different forms of dementia and sera of 82 age-matched patients with various neurological diseases except for dementia, as well as sera from 15 age-matched healthy controls were analyzed for anti-glial or anti-neuronal IgG using 1) primary murine embryonic hippocampus cell cultures, 2) murine brain sections, 3) immunoblotting on mouse brain homogenates and 4) astrocyte cultures. Sera reacting with astrocytes in hippocampus cell cultures were further analyzed using HEK293 cells transfected with human GFAP., Results: IgG in serum from 45 of 127 (35.5%) patients with dementia but only 8 of 97 (8.2%, p ≤ 0.001) controls bound to either glial or neuronal structures in cultured murine hippocampus cells. In these cultures antibodies to astrocytes were detected in 35 of 127 (27.5%) of the dementia patients, whereas in controls antibodies to astrocytes were detected in 4 sera only (4.1%, p ≤ 0.001). Among the sera exhibiting reactivity to astrocytes, 14 of 35 (40%) showed immunoreaction to HEK293 cells transfected with GFAP in dementia patients, representing 11% of all sera. Within the 4 immunoreactive control sera reacting with astrocytes one reacted with GFAP (1.0% of total immunoreactivity, p = 0.003)., Conclusions: Autoantibodies to glial epitopes in general and to GFAP in particular are more frequent in patients with dementia than in age-matched controls without dementia, thus indicating the need for further investigations regarding the potential pathophysiological relevance of these antibodies., Competing Interests: All authors of the manuscript “Immunoreactivity to astrocytes in different forms of dementia: high prevalence of autoantibodies to GFAP” report no conflicts of interest., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
44. Brain blood vessel autoantibodies in patients with NMDA and GABA A receptor encephalitis: identification of unconventional Myosin-X as target antigen.
- Author
-
Li LY, Kreye J, Burek M, Cordero-Gomez C, Barthel PC, Sánchez-Sendín E, Kornau HC, Schmitz D, Scharf M, Meybohm P, Reincke SM, Prüss H, and Höltje M
- Abstract
Introduction: The antibody repertoire from CSF-derived antibody-secreting cells and memory B-cells in patients with encephalitis contains a considerable number of antibodies that do not target the disease-defining autoantigen such as the GABA or NMDA receptors. This study focuses on the functional relevance of autoantibodies to brain blood vessels in patients with GABA
A and NMDA receptor encephalitis. Methods: We tested 149 human monoclonal IgG antibodies from the cerebrospinal fluid of six patients with different forms of autoimmune encephalitis on murine brain sections for reactivity to blood vessels using immunohistochemistry. Positive candidates were tested for reactivity with purified brain blood vessels, effects on transendothelial electrical resistance (TEER), and expression of tight junction proteins as well as gene regulation using human brain microvascular endothelial hCMEC/D3 cells as in vitro blood-brain barrier model. One blood-vessel reactive antibody was infused intrathecally by pump injection in mice to study in vivo binding and effects on tight junction proteins such as Occludin. Target protein identification was addressed using transfected HEK293 cells. Results: Six antibodies reacted with brain blood vessels, three were from the same patient with GABAA R encephalitis, and the other three were from different patients with NMDAR encephalitis. One antibody from an NMDAR encephalitis patient, mAb 011-138, also reacted with cerebellar Purkinje cells. In this case, treatment of hCMEC/D3 cells resulted in decreased TEER, reduced Occludin expression, and mRNA levels. Functional relevance in vivo was confirmed as Occludin downregulation was observed in mAb 011-138-infused animals. Unconventional Myosin-X was identified as a novel autoimmune target for this antibody. Discussion: We conclude that autoantibodies to blood vessels occur in autoimmune encephalitis patients and might contribute to a disruption of the blood-brain barrier thereby suggesting a potential pathophysiological relevance of these antibodies., Competing Interests: MS was employed by the company EUROIMMUN AG, Lübeck, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Li, Kreye, Burek, Cordero-Gomez, Barthel, Sánchez-Sendín, Kornau, Schmitz, Scharf, Meybohm, Reincke, Prüss and Höltje.)- Published
- 2023
- Full Text
- View/download PDF
45. A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model.
- Author
-
Kreye J, Reincke SM, Kornau HC, Sánchez-Sendin E, Max Corman V, Liu H, Yuan M, Wu NC, Zhu X, Lee CD, Trimpert J, Höltje M, Dietert K, Stöffler L, von Wardenburg N, van Hoof S, Homeyer MA, Hoffmann J, Abdelgawad A, Gruber AD, Bertzbach LD, Vladimirova D, Li LY, Barthel PC, Skriner K, Hocke AC, Hippenstiel S, Witzenrath M, Suttorp N, Kurth F, Franke C, Endres M, Schmitz D, Jeworowski LM, Richter A, Schmidt ML, Schwarz T, Müller MA, Drosten C, Wendisch D, Sander LE, Osterrieder N, Wilson IA, and Prüss H
- Abstract
The emergence of SARS-CoV-2 led to pandemic spread of coronavirus disease 2019 (COVID-19), manifesting with respiratory symptoms and multi-organ dysfunction. Detailed characterization of virus-neutralizing antibodies and target epitopes is needed to understand COVID-19 pathophysiology and guide immunization strategies. Among 598 human monoclonal antibodies (mAbs) from ten COVID-19 patients, we identified 40 strongly neutralizing mAbs. The most potent mAb CV07-209 neutralized authentic SARS-CoV-2 with IC50 of 3.1 ng/ml. Crystal structures of two mAbs in complex with the SARS-CoV-2 receptor-binding domain at 2.55 and 2.70 A revealed a direct block of ACE2 attachment. Interestingly, some of the near-germline SARS-CoV-2 neutralizing mAbs reacted with mammalian self-antigens. Prophylactic and therapeutic application of CV07-209 protected hamsters from SARS-CoV-2 infection, weight loss and lung pathology. Our results show that non-self-reactive virus-neutralizing mAbs elicited during SARS-CoV-2 infection are a promising therapeutic strategy.
- Published
- 2020
- Full Text
- View/download PDF
46. The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif.
- Author
-
Rohrbeck A, Höltje M, Adolf A, Oms E, Hagemann S, Ahnert-Hilger G, and Just I
- Subjects
- Amino Acid Motifs, Animals, Cell Line, Mice, Vimentin chemistry, Vimentin genetics, Vimentin metabolism, ADP Ribose Transferases chemistry, ADP Ribose Transferases pharmacokinetics, ADP Ribose Transferases pharmacology, Botulinum Toxins chemistry, Botulinum Toxins pharmacokinetics, Botulinum Toxins pharmacology, Integrin beta1 chemistry, Integrin beta1 genetics, Integrin beta1 metabolism, Neurons metabolism, Oligopeptides, Synaptosomes metabolism
- Abstract
The Rho ADP-ribosylating C3 exoenzyme (C3bot) is a bacterial protein toxin devoid of a cell-binding or -translocation domain. Nevertheless, C3 can efficiently enter intact cells, including neurons, but the mechanism of C3 binding and uptake is not yet understood. Previously, we identified the intermediate filament vimentin as an extracellular membranous interaction partner of C3. However, uptake of C3 into cells still occurs (although reduced) in the absence of vimentin, indicating involvement of an additional host cell receptor. C3 harbors an Arg-Gly-Asp (RGD) motif, which is the major integrin-binding site, present in a variety of integrin ligands. To check whether the RGD motif of C3 is involved in binding to cells, we performed a competition assay with C3 and RGD peptide or with a monoclonal antibody binding to β1-integrin subunit and binding assays in different cell lines, primary neurons, and synaptosomes with C3-RGD mutants. Here, we report that preincubation of cells with the GRGDNP peptide strongly reduced C3 binding to cells. Moreover, mutation of the RGD motif reduced C3 binding to intact cells and also to recombinant vimentin. Anti-integrin antibodies also lowered the C3 binding to cells. Our results indicate that the RGD motif of C3 is at least one essential C3 motif for binding to host cells and that integrin is an additional receptor for C3 besides vimentin., (© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
47. Intrathecal immunoglobulin A and G antibodies to synapsin in a patient with limbic encephalitis.
- Author
-
Piepgras J, Höltje M, Otto C, Harms H, Satapathy A, Cesca F, Benfenati F, Gitler D, Pich A, Zander JF, Ahnert-Hilger G, and Ruprecht K
- Abstract
Objective: To report on the identification of intrathecally synthesized immunoglobulin A (IgA) and immunoglobulin G (IgG) antibodies to synapsin, a synaptic vesicle-associated protein, in a patient with limbic encephalitis., Methods: Methods included clinical characterization, indirect immunofluorescence, immunoprecipitation, mass spectrometry, immunoblots of wild-type and synapsin I/II/III knockout mice, and cell-based assays with synapsin Ia, Ib, IIa, and IIb plasmids., Results: A 69-year-old man presented with confusion, disorientation, seizures, and left hippocampal hyperintensities on MRI. CSF examinations revealed an intrathecal IgA and IgG synthesis. Except for IgG antibodies to voltage-gated potassium channels in CSF, screening for known neuronal autoantibodies in serum and CSF was negative. However, indirect immunofluorescence using the patient's CSF showed binding of IgA to mouse hippocampus, amygdala, and cerebellum. Immunoprecipitation with CSF IgA followed by mass spectrometry identified synapsin as autoantigenic target. Knockout tissues and cell-based assays confirmed that IgA and IgG in the patient's CSF and serum reacted with synapsin Ia, Ib, and IIa. Calculation of antibody indices proved intrathecal synthesis of anti-synapsin IgA and IgG. The patient responded clinically to immunotherapy but developed left hippocampal atrophy. CSF IgA or IgG of the patient did not bind to live, unfixed, and nonpermeabilized mouse hippocampal neurons, compatible with synapsin being an intracellular antigen., Conclusions: This report identifies isoforms of the synaptic vesicle-associated protein synapsin as targets of intrathecally produced IgA and IgG antibodies in a patient with limbic encephalitis. Future studies should clarify the prevalence and pathogenic relevance of anti-synapsin antibodies in limbic encephalitis.
- Published
- 2015
- Full Text
- View/download PDF
48. Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.
- Author
-
Ahnert-Hilger G, Münster-Wandowski A, and Höltje M
- Subjects
- Animals, Botulinum Toxins toxicity, Botulism microbiology, Botulism physiopathology, Cell Membrane metabolism, Clostridium botulinum pathogenicity, Exocytosis, Membrane Fusion, Membrane Glycoproteins metabolism, Mice, Nerve Tissue Proteins metabolism, Neurons metabolism, Neurons microbiology, Neurotoxins toxicity, Protein Transport, Proteolysis, Synaptic Transmission, Synaptosomal-Associated Protein 25 metabolism, Synaptotagmins metabolism, Botulinum Toxins metabolism, Neurotoxins metabolism, Synaptic Vesicles metabolism
- Abstract
Synaptic vesicles (SV) are key organelles of neuronal communication. SV are responsible for the storage of neurotransmitters, which are released by Ca(2+)-dependent exocytosis. After release and interaction with postsynaptic receptors, transmitters rapidly diffuse out of the synaptic cleft and are sequestered by plasma membrane transporters (in some cases following enzymatic conversion). SVs undergo endocytosis and are refilled by specific vesicular transmitter transporters different in the various neuronal subtypes. Besides these differences, SVs in general are equipped with a remarkable common set of proteins. Botulinum neurotoxins (BoNTs) inhibit neurotransmitter release from almost all types of neurons by cleaving proteins required for membrane fusion localized either to SVs (synaptobrevin) or to the plasma membrane (SNAP-25 and syntaxin) depending on the BoNT serotype. To enter the neuronal cytoplasm, BoNTs specifically interact with the luminal domain of SV proteins (synaptotagmin or SV2, depending on serotype) transiently exposed during exocytotic membrane fusion and occurring in almost every neuron. Thus, the highly specific interaction with luminal domains of SV proteins commonly expressed on all SV types is one reason why BoNTs exhibit such a high neuronal specificity but attack almost every neuron type.
- Published
- 2013
- Full Text
- View/download PDF
49. Rho-independent stimulation of axon outgrowth and activation of the ERK and Akt signaling pathways by C3 transferase in sensory neurons.
- Author
-
Auer M, Schweigreiter R, Hausott B, Thongrong S, Höltje M, Just I, Bandtlow C, and Klimaschewski L
- Abstract
Peripheral nerve injury triggers the activation of RhoA in spinal motor and peripheral sensory neurons. RhoA activates a number of effector proteins including the Rho-associated kinase, ROCK, which targets the cytoskeleton and leads to inhibition of neurite outgrowth. Blockade of the Rho/ROCK pathway by pharmacological means improves axon regeneration after experimental injury. C3(bot) transferase, an exoenzyme produced by Clostridium botulinum, inactivates RhoA by ADP-ribosylation. It has been successfully applied in experimental CNS lesions to facilitate axon regeneration. Up to now it was not investigated thoroughly whether C3(bot) exerts positive effects on peripheral axon regeneration as well. In the present study, recombinant membrane permeable C3(bot) produced a small, but significant, axon outgrowth effect on peripheral sensory neurons dissociated from adult dorsal root ganglia (DRG) of the rat. Neuronal overexpression of C3, however, did not enhance axonal growth. Moreover, transfection of plasmids encoding dominant negative RhoA or RhoA specific shRNAs failed to increase axonal growth. Furthermore, we show that the C3(bot) mutant, C3(E174Q), which lacks RhoA inhibitory activity, still stimulates axonal growth. When analyzing possible signaling mechanisms we found that extracellular signal-regulated kinase (ERK) and Akt are activated by C3(bot) and ERK is induced by the C3(E174Q) mutant. Upregulation of kinase activities by C3(bot) occurs significantly faster than inactivation of RhoA indicating a RhoA-independent pathway of action by C3(bot). The induction of ERK signaling by C3(bot) was detected in embryonic hippocampal neurons, too. Taken together, although RhoA plays a central role for inhibition of axon outgrowth by myelin-derived inhibitors, it does not interfere with axonal growth of sensory neurons on a permissive substrate in vitro. C3(bot) blocks neuronal RhoA activity, but its positive effects on axon elongation and branching appear to be mediated by Rho independent mechanisms involving activation of axon growth promoting ERK and Akt kinases.
- Published
- 2012
- Full Text
- View/download PDF
50. The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake.
- Author
-
Brunk I, Blex C, Rachakonda S, Höltje M, Winter S, Pahner I, Walther DJ, and Ahnert-Hilger G
- Subjects
- Animals, CHO Cells, Cricetinae, Down-Regulation, Epinephrine metabolism, Guanylyl Imidodiphosphate pharmacology, Ligands, Mice, Protein Isoforms metabolism, Vesicular Monoamine Transport Proteins genetics, GTP-Binding Proteins metabolism, Serotonin metabolism, Vesicular Monoamine Transport Proteins metabolism
- Abstract
The activity of vesicular monoamine transporters (VMATs) is down-regulated by the G-protein alpha-subunits of G(o2) and G(q), but the signaling pathways are not known. We show here that no such regulation is observed when VMAT1 or VMAT2 are expressed in Chinese hamster ovary (CHO) cells. However, when the intracellular compartments of VMAT-expressing CHO cells are preloaded with different monoamines, transport becomes susceptible to G-protein-dependent regulation, with differences between the two transporter isoforms. Epinephrine induces G-protein-mediated inhibition of transmitter uptake in CHOVMAT1 cells but prevents inhibition induced by dopamine in CHOVMAT2 cells. Epinephrine also antagonizes G-protein-mediated inhibition of monoamine uptake by VMAT2 expressing platelets or synaptic vesicles. In CHOVMAT2 cells G-protein-mediated inhibition of monoamine uptake can be induced by 5-hydroxytryptamine (serotonin) 1B receptor agonists, whereas alpha1 receptor agonists modulate uptake into CHOVMAT1 cells. Accordingly, 5-hydroxytryptamine 1B receptor antagonists prevent G-protein-mediated inhibition of uptake in partially filled platelets and synaptic vesicles expressing VMAT2. CHO cells expressing VMAT mutants with a shortened first vesicular loop transport monoamines. However, no or a reduced G-protein regulation of uptake can be initiated. In conclusion, vesicular content is involved in the activation of vesicle associated G-proteins via a structure sensing the luminal monoamine content. The first luminal loop of VMATs may represent a G-protein-coupled receptor that adapts vesicular filling.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.